Redcare Pharmacy Shares Show Signs of a Potential Reversal
Published on 11/28/2025 at 12:52 | Redaktion boerse-global.de
After months of disappointing performance that saw its value cut in half since the start of the year, Redcare Pharmacy is exhibiting tentative signals of a technical recovery. The stock has recently detached from its 52-week low and is gradually climbing higher. Market participants are now questioning whether this represents a temporary pause in the downward trend or the foundation for a more sustained upward movement.
The company’s future trajectory heavily depends on its operational execution. Management recently reaffirmed its full-year guidance, maintaining the target of achieving over 25% revenue growth for 2025. Furthermore, the adjusted EBITDA margin is projected to land between 2% and 2.5% in the fourth quarter.
While these commitments Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
